Docking studies reveal a selective binding of D-penicillamine to the transactivator protein of human immunodeficiency virus type 1.
Demirhan I, Kanyalkar M, Chandra A, Doerr HW, Coutinho E, Loewer J, Saran A, Chandra P, FEBS Lett, 2002 Apr 10 - link